Atypical antipsychotics: matching receptor profile to individual patient's clinical profile (Q45099748)

9 December 2017

title

Atypical antipsychotics: matching receptor profile to individual patient's clinical profile (English)

1 reference

9 December 2017

2

Stephen M Stahl

1 reference

9 December 2017

Darius K Shayegan

1

1 reference

9 December 2017

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

9

1 reference

9 December 2017

issue

10 Suppl 11

1 reference

9 December 2017

page(s)

6-14

1 reference

The effect of neuroleptics on cognitive and psychomotor function

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

The "psychic" neuron of the cerebral cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Dose response and dose equivalence of antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Dose response and atypical antipsychotics in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Neurobiological mechanisms involved in antidepressant therapies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Role of risperidone in bipolar II: an open 6-month study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Three Potential Susceptibility Loci Shown by a Genome-Wide Scan for Regions Influencing the Age at Onset of Mania

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

The physiological role of 5-HT2A receptors in working memory

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

"Hit-and-run" actions at dopamine receptors, part 1: Mechanism of action of atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900025086

7 January 2021

10.1017/S1092852900025086

Identifiers

DOI

0 references

1 reference